Several brokerages have updated their recommendations and price targets on shares of ON (NYSE: ONON) in the last few weeks: 11/10/2025 – ON had its price target lowered by analysts at Truist Financial Corporation from $69.00 to $60.00. They now have a “buy” rating on the stock. 11/10/2025 – ON had its price target lowered […]

A number of firms have modified their ratings and price targets on shares of AXT (NASDAQ: AXTI) recently: 10/31/2025 – AXT was given a new $10.00 price target on by analysts at Northland Securities. 10/31/2025 – AXT had its price target raised by analysts at B. Riley from $4.00 to $9.00. They now have a […]

Several brokerages have updated their recommendations and price targets on shares of Boise Cascade (NYSE: BCC) in the last few weeks: 11/7/2025 – Boise Cascade was downgraded by analysts at Weiss Ratings from a “hold (c-)” rating to a “sell (d+)” rating. 11/5/2025 – Boise Cascade was upgraded by analysts at BMO Capital Markets from […]

AstraZeneca (LON: AZN) has recently received a number of price target changes and ratings updates: 11/10/2025 – AstraZeneca had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co.. 11/10/2025 – AstraZeneca had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a £150 price target on the stock. […]

Aecon Group (OTCMKTS: AEGXF) has recently received a number of price target changes and ratings updates: 11/3/2025 – Aecon Group had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. 10/31/2025 – Aecon Group had its “outperform” rating reaffirmed by analysts at National Bankshares, Inc.. 10/31/2025 – Aecon Group had its “buy” […]

Ventyx Biosciences (NASDAQ: VTYX) recently received a number of ratings updates from brokerages and research firms: 11/7/2025 – Ventyx Biosciences had its price target raised by analysts at Canaccord Genuity Group Inc. from $14.00 to $16.00. They now have a “buy” rating on the stock. 11/7/2025 – Ventyx Biosciences had its price target raised by […]

A number of firms have modified their ratings and price targets on shares of Abercrombie & Fitch (NYSE: ANF) recently: 11/4/2025 – Abercrombie & Fitch had its price target lowered by analysts at Citigroup Inc. from $105.00 to $79.00. They now have a “neutral” rating on the stock. 10/30/2025 – Abercrombie & Fitch had its […]

Several analysts have recently updated their ratings and price targets for Taysha Gene Therapies (NASDAQ: TSHA): 11/8/2025 – Taysha Gene Therapies was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating. 11/5/2025 – Taysha Gene Therapies was given a new $8.00 price target on by analysts at JMP Securities. […]

M&T Bank (NYSE: MTB) has recently received a number of price target changes and ratings updates: 11/7/2025 – M&T Bank was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating. 11/1/2025 – M&T Bank was upgraded by analysts at Wall Street Zen from a “sell” rating to a […]

Evaxion A/S (NASDAQ: EVAX) recently received a number of ratings updates from brokerages and research firms: 10/30/2025 – Evaxion A/S is now covered by analysts at Edward Jones. They set a “buy” rating and a $10.00 price target on the stock. 10/29/2025 – Evaxion A/S was upgraded by analysts at Jones Trading to a “strong-buy” […]

KNOT Offshore Partners (NYSE: KNOP) recently received a number of ratings updates from brokerages and research firms: 11/9/2025 – KNOT Offshore Partners was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating. 11/3/2025 – KNOT Offshore Partners was downgraded by analysts at B. Riley from a “strong-buy” rating to […]